Merck & Co. Inc. filed a lawsuit on Thursday in West Virginia federal court seeking to block competing drug maker Mylan NV from moving ahead with plans to sell generic versions of two diabetes drugs that Merck says would infringe patents it owns.

Read this piece in its entirety at Law360.